About
Technology
Issues
FAQ
Links
Official Page
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.